… In another analysis of the dynamics of neutralizing antibody titers in eight convalescent
patients with COVID-19, four patients showed decreased neutralizing antibodies approximately 6…

… In conclusion, antibodies appear to have antiviral effects in the early stages of SARS-CoV-2
infection, and the most symptomatic patients with COVID-19 remain positive for IgG-S and …

… Convalescent plasma is safe, does not improve survival, has … respiratory tract, influence
SARS-CoV-2 antibody development or … of patients already had potent neutralizing SARS-CoV-2 …

… Could plasma collected from COVID-19 convalescent patients be efficacious in treating
patients still battling the infection, or as a prophylactic approach to prevent this disease? In this …

… immune responses to SARS-CoV-2 infection. Here, we collected blood from COVID-19
patients who have recently become virusfree, and therefore were discharged, and detected …

… In the USA, the first patient infected with SARS-CoV-2 was treated by supportive care and …
therapeutic against SARS coronavirus 2 (SARS-CoV-2; the causative organism in COVID-19). …

… % on days 31–40 post symptom onset to 28% on days 41–53 [12], and decreasing neutralising
antibody levels have also been noted in SARS-CoV-2 infected hospitalised patients [17]. …

… SARS-CoV-2 VOCs, sera were collected from patients with … In summary, using convalescent
sera from individuals infected … Infection with B.1.1.7, B.1.351 or B.1.617.2 generates a cross-…

… convalescent coronavirus disease 2019 (COVID-19) patients … syndrome coronavirus-2
(SARSCoV-2) infection and thus … against this emerging virus. Although the serum levels of anti-…

… optimal convalescent plasma donors. The aim of this study was to characterize SARS-CoV-2 …
and convalescent patients, and compare their association with neutralizing antibody titers. …